Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.63 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.63 |
| ▸ | ITGAL | P20701 | 1/20 | 0.63 |
| ▸ | CA4 | P22748 | 1/20 | 0.63 |
| ▸ | CA6 | P23280 | 1/20 | 0.63 |
| ▸ | AHR | P35869 | 1/20 | 0.63 |
| ▸ | ADK | P55263 | 1/20 | 0.63 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.47 |
| ▸ | WNT3A | P56704 | 2/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Indole SCHEMBL31188952 | 1.00 | TRPA1 (0.63) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL28129119 | 1.00 | TRPA1 (0.63) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL20529585 | 0.92 | TRPA1 (0.53) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL28833831 | 0.89 | TRPA1 (0.63) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL2347749 | 0.88 | TRPA1 (0.57) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL412813 | 0.88 | TRPA1 (0.57) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL1714302 | 0.87 | TRPA1 (0.61) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL1714414 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL6835663 | 0.87 | TRPA1 (0.65) | TRPA1CA1CA2ITGB2ICAM1 | |
| Indole SCHEMBL15552 | 0.86 | TRPA1 (0.71) | TRPA1CA1CA2ITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12633376-B2 | System and method for risk assessment of autism spectrum disorder | TATA CONSULTANCY SERVICES LIMITED (IN) | 2026-05-19 | — | — | US | claimed |
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | UNIV IOWA RES FOUND (US) | 2026-02-26 | — | — | US | claimed |
| US-20250367246-A1 | IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES | SOLAREA BIO INC (US) | 2025-12-04 | — | — | US | claimed |
| US-20250356948-A1 | SYSTEM AND METHOD FOR RISK ASSESSMENT OF AUTISM SPECTRUM DISORDER | TATA CONSULTANCY SERVICES LIMITED (IN) | 2025-11-20 | — | — | US | claimed |
| US-12440523-B2 | Immunomodulatory compositions comprising microbial entities | SOLAREA BIO, INC. (US) | 2025-10-14 | — | — | US | claimed |
| CN-119951426-A | Double-network gel microsphere with pH response and preparation method and application thereof | 合肥工业大学 | 2025-05-09 | — | — | CN | claimed |
| CN-118931933-A | Recombinant vector for biosynthesis of indopropionic acid, engineering bacterium and application thereof | 镇江市天益生物科技有限公司 | 2024-11-12 | — | — | CN | claimed |
| EP-4452287-A2 | IMMUNOMODULATORY COMPOSITIONS COMPRISING MICROBIAL ENTITIES | Solarea Bio, Inc. (US) | 2024-10-30 | — | — | EP | claimed |
| CN-118831071-A | Sequential multistage targeted delivery system for repairing intestinal barrier and preparation method thereof | 大连理工大学 | 2024-10-25 | — | — | CN | claimed |
| CN-118696825-A | Liaodong clove immature embryo regeneration method | 青海省农林科学院 | 2024-09-27 | — | — | CN | claimed |
| US-20050197253-A1 | Methods for improving growth and crop productivity of plants by adjusting plant hormone levels, ratios and/or co-factors | BANK OF AMERICA, NA | 2005-09-08 | — | — | US | claimed |
| WO-2005021715-A2 | METHODS FOR IMPROVING GROWTH AND CROP PRODUCTIVITY OF PLANTS BY ADJUSTING PLANT HORMONE LEVELS, RATIOS AND/OR CO-FACTORS | STOLLER ENTERPRISES, INC. (US) | 2005-03-10 | — | — | WO | claimed |
| WO-2005018319-A2 | SUPPRESSING PLANT PATHOGENS AND PESTS WITH APPLIED OR INDUCED AUXINS | STOLLER ENTERPRISES, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| US-20050043177-A1 | Controlling plant pathogens and pests with applied or induced auxins | BANK OF AMERICA, NA | 2005-02-24 | — | — | US | claimed |
| EP-1372571-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | New Century Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | NEW CENTURY PHARMACEUTICALS, INC. | 2002-12-19 | — | — | US | claimed |
| WO-2002074246-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1171603-A1 | A PROCESS FOR PRODUCING PURIFIED BIOLOGICALLY ACTIVE, FREE FORM OF RECOMBINANT HUMAN INTERFERON GAMMA | Vyas, Sharad Kumar (IN) | 2002-01-16 | — | — | EP | claimed |
| WO-2001057218-A1 | A PROCESS FOR PRODUCING PURIFIED BIOLOGICALLY ACTIVE, FREE FORM OF RECOMBINANT HUMAN INTERFERON GAMMA | VYAS SHARAD KUMAR (IN) | 2001-08-09 | — | — | WO | claimed |
| EP-0175577-A2 | Microchemiluminescent assay system | Kiel, Jonathan L (US) | 1986-03-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12633376-B2 | System and method for risk assessment of autism spectrum disorder | TPH1, KYNU, TPH2 | TRPA1 2104/4885CA1 2995/4885CA2 3169/4885 |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | ALB, TYMP, SHBG | TRPA1 4851/4885CA1 3364/4885CA2 4399/4885 |
| US-20260053887-A1 | Methods and Kits to Prevent And/Or Treat Cardiac Disorders | KYNU, AADAT, TPH1 | TRPA1 1052/4885CA1 2837/4885CA2 2711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.